SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001144204-12-023739
Filing Date
2012-04-25
Accepted
2012-04-25 16:01:58
Documents
13
Reference 429
333-175726

Document Format Files

Seq Description Document Type Size
1 FORM S-1 v310355_s1.htm S-1 1072011
2 EXHIBIT 5.2 v310355_ex5-2.htm EX-5.2 6927
3 EXHIBIT 23.1 v310355_ex23-1.htm EX-23.1 2372
10 GRAPHIC footer.jpg GRAPHIC 21608
11 GRAPHIC logo.jpg GRAPHIC 14728
12 GRAPHIC logo1.jpg GRAPHIC 20245
13 GRAPHIC logo2.jpg GRAPHIC 6494
  Complete submission text file 0001144204-12-023739.txt   3015009

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nltx-20111231.xml EX-101.INS 300758
5 XBRL TAXONOMY EXTENSION SCHEMA nltx-20111231.xsd EX-101.SCH 20458
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nltx-20111231_cal.xml EX-101.CAL 32846
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nltx-20111231_def.xml EX-101.DEF 105461
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nltx-20111231_lab.xml EX-101.LAB 140222
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nltx-20111231_pre.xml EX-101.PRE 125290
Mailing Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402
Business Address 4 WEST 4TH AVE SUITE 400 SAN MATEO CA 94402 650-458-2678
Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-180928 | Film No.: 12779613
SIC: 2834 Pharmaceutical Preparations